Lipocortin 1: Glucocorticoids caught in the act?

Thorax

Volumn 51, Issue 10, 1996, Pages 1057-1059

  Smith, Susan F ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Glucocorticoid; Lipocortin 1; Respiratory tract

Indexed keywords

GLUCOCORTICOID; LIPOCORTIN 1;

ANTIINFLAMMATORY ACTIVITY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SHORT SURVEY;

EID: 0029845460     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.10.1057     Document Type: Short Survey

References (12)

1. Moss SE. The annexins. In: Moss SE, ed. The annexins. London: Portland Press, 1992:1-10.
2. Fava RA, McKanna J, Cohen SI. Lipocortin 1 is abundant in a restricted number of differentiated cell types in adult organs. J Cell Physiol 1989;141:284-93.
3. Smith SF, Tetley TD, Datta AK, Smith T, Guz A, Flower RJ. Lipocortin-1 distribution in bronchoalveolar lavage from healthy human lung: effect of prednisolone. J Appl Physiol 1995;79:121-8.
4. De Caterina R, Sicari R, Giannessi D, Paggiaro PL, Paoletti P, Lazzerinin, et al. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol 1993;75:2368-75.
5. van Hal PThW, Overbeek SE, Hoogsteden HC, Zijlstra FJ, Murphy K, Oosterhoff Y, et al. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids J Appl Physiol 1996 (in press).
6. Smith SF, Tetley TD, Guz A, Flower RJ. Detection of lipocortin 1 in human lung lavage fluid; lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation. Environ Health Perspect 1990;85:135-44.
7. Browning JL, Ward MP, Wallner BP, Pepinsky RB. Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids. In: Melli M, Parente L, eds. Cytokines and lipocortins in inflammation and differentiation. New York: Wiley-Liss, 1990: 27-45.
8. Flower RJ, Rothwell NJ. Lipocortin 1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994;15:71-6.
9. Perretti M. Lipocortin-derived peptides. Biochem Pharmacol 1994;47:931-8.
10. Wu C-C, Croxtall JD, Perretti M, Bryant CE, Thiermermann C, Flower RJ, et al. Lipocortin 1 mediates the inhibition of dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 1995;92:3473-7.
11. Goulding NJ, Luying P, Guyre PM. Characteristics of lipocortin 1 binding to the surface of human peripheral blood leukocytes. Biochem Soc Trans 1990;18:1237-8.
12. 2 activity. Biochem Pharmacol 1995;50:465-74.